SEC Form 4 · accession 0001493152-26-028766
Apyx Medical Corp · APYX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew C Hill
Officer — Chief Financial Officer
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 7:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000719135
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Option to Buy)F1 | $4.65 | Jun 11, 2026 | A | 132,066 | A | — | Jun 11, 2036 | Common Stock | 132,066 | 132,066 | D |
Explanation of responses
- F1Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.